“Our vaccine is currently undergoing clinical trials.
We have risen from 300 people, whom we planned to employ in the first or second phase, to 600 people, because we see the situation around criticism of all vaccines - not only domestic, but also foreign ones, ”he said on the air of the Russia 24 TV channel. ...
In this regard, according to Chernov, the publication of the results of vaccine tests at the Chumakov Center may be delayed by two to three weeks.
“We are going to apply for registration sometime in late January - early February ... and in parallel with this we will launch, of course, the third phase in order to register it not under the temporary 441st government decree, but under the permanent 61-FZ ", - he specified.
The deputy director general of the Chumakov Center also said that in addition to research centers in St. Petersburg, Kirov and Novosibirsk, a center in Yekaterinburg had joined the vaccine trials.
In October, the Chumakov center reported that they plan to submit documents to the Ministry of Health in mid-December to register the third Russian vaccine against coronavirus.
On October 6, the Chumakov Center began clinical trials of its own vaccine against coronavirus.